World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
68493
World Ranking
2917
National Ranking
297

Overview

Gavin Giovannoni is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily falls within the field of Medicine, with particular focus on several subfields including Pathology and Forensic Medicine, Neurology, Epidemiology, Immunology, and Molecular Biology.

The main topics covered in Giovannoni's work involve Multiple Sclerosis Research Studies, Sphingolipid Metabolism and Signaling, Polyomavirus and related diseases, Systemic Lupus Erythematosus Research, Peripheral Neuropathies and Disorders, Phytochemistry and Biological Activities, and Fungal Infections and Studies.

Giovannoni has contributed to multiple papers related to Multiple Sclerosis and neurodegenerative diseases. Selected recent publications include:

  • Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study, 2020, Journal of Neurology Neurosurgery & Psychiatry
  • Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years, 2022, Multiple Sclerosis Journal
  • Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial, 2022, Multiple Sclerosis Journal
  • Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study, 2020, Journal of Neurology
  • Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study, 2020, Multiple Sclerosis Journal

Giovannoni frequently collaborates with several researchers, including:

  • Douglas L. Arnold
  • Amit Bar-Or
  • Ralf Gold
  • Ludwig Kappos
  • Robert J. Fox

The researcher's work is published predominantly in the following venues:

  • Multiple Sclerosis Journal
  • Journal of Neurology Neurosurgery & Psychiatry
  • Revue Neurologique
  • Journal of Neurology
  • Neurology

Best Publications

  • A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

    Chris H. Polman;Eva Havrdova;Michael Hutchinson;Ludwig Kappos

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    Ralf Gold;Ludwig Kappos;Douglas L Arnold;Amit Bar-Or

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Multiple Sclerosis - A Review

    R. Dobson;G. Giovannoni

  • Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

    Jeffrey A. Cohen;Alasdair J. Coles;Douglas L. Arnold;Christian Confavreux

  • A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.

    Sreeram V. Ramagopalan;Andreas Heger;Antonio J. Berlanga;Narelle J. Maugeri

  • A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

    Gavin Giovannoni;Giancarlo Comi;Stuart Cook;Kottil Rammohan

  • Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

    Alastair J Noyce;Jonathan P Bestwick;Laura Silveira-Moriyama;Laura Silveira-Moriyama;Christopher H Hawkes

  • A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

    Charlotte Teunissen;Axel Petzold;Jeffrey L. Bennett;Frode S. Berven

  • The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

    R. B. Banati;J. Newcombe;R. N. Gunn;A. Cagnin

  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement

    Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni

  • Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

    David B Clifford;Andrea DeLuca;David M Simpson;Gabriele Arendt

  • Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

    G Giovannoni;J D O'Sullivan;K Turner;A J Manson

  • Multiple sclerosis: risk factors, prodromes, and potential causal pathways

    Sreeram V Ramagopalan;Ruth Dobson;Ute C Meier;Gavin Giovannoni

  • The therapeutic potential of cannabis

    David Baker;Gareth Pryce;Gavin Giovannoni;Alan J Thompson

  • Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

    Ching-Hua Lu;Corrie Macdonald-Wallis;Elizabeth Gray;Neil Pearce

  • Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

    Johanna Gaiottino;Niklas Norgren;Ruth Dobson;Joanne Topping

  • Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

    Eva Havrdova;Steven Galetta;Michael Hutchinson;Dusan Stefoski

  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis

    Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni

Frequent Co-Authors

Eva Havrdova
Eva Havrdova Charles University
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
David Baker
David Baker University of Washington
Sreeram V. Ramagopalan
Sreeram V. Ramagopalan University of Oxford
Patrick Vermersch
Patrick Vermersch University of Lille
Ralf Gold
Ralf Gold Ruhr University Bochum
Douglas L. Arnold
Douglas L. Arnold Montreal Neurological Institute and Hospital
Krzysztof Selmaj
Krzysztof Selmaj University of Warmia and Mazury in Olsztyn
Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor. There are multiple related degrees and pathways that can open doors in healthcare, many of which now offer flexible online options. Registered nurses interested in furthering their careers can explore rn to np programs, allowing them to become nurse practitioners through streamlined bridge programs.

For those passionate about health and wellness, earning a nutrition bachelor degree online can lead to dynamic roles in dietetics, public health, or private practice. If your interest lies in the business and organizational side of healthcare, consider enrolling in accredited mha programs to gain administrative expertise required for leadership roles in hospitals and care facilities.

Additionally, working nurses seeking advanced credentials often look for flexibility. There are even rn to bsn no clinical hours programs, which enable professionals to earn their degree without additional on-site clinical requirements. These diverse online pathways provide valuable alternatives and advancement opportunities in the rapidly evolving healthcare sector.

Best Scientists Citing Gavin Giovannoni

Trending Scientists